Join
Live feed
·
PRReleasevia Quantisnow
MannKind Corporation logo
United Therapeutics Corporation logo

MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

ByQuantisnow·Wall Street's wire, on your screen.
MNKD· MannKind CorporationUTHR· United Therapeutics Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MNKD (MannKind Corporation), UTHR (United Therapeutics Corporation) and more on Quantisnow.